Processa Pharmaceuticals, Inc. — Director's Dealing 2025

Apr 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-04-01

Reporting Person: Young David (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-01	Common Stock	M	17272	—	Acquired	222677	Direct
2025-04-01	Common Stock	F	5345	$0.412	Disposed	217332	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	30985	Indirect
Common Stock	10786	Indirect
Common Stock	18544	Indirect

Footnotes

F1: Distribution of vested restricted shares.